10x Genomics (TXG)

• Market cap: $1.08B
• 1 day: 0.69%
• 5 days: -9.85%
• 1 month: -10.76%
• 3 months: -38.05%
• 6 months: -58.75%
• Year to date: -38.05%
• 1 year: -76.28%
• 5 years: -84.95%
• 10 years: -83.34%
• Sector: Industrials
• Industry: Laboratory Analytical Instruments

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

29% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 49

3% more funds holding

Funds holding: 262 [Q3] → 270 (+8) [Q4]

0.3% less ownership

Funds ownership: 98.36% [Q3] → 98.06% (-0.3%) [Q4]

4% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 91

31% less call options, than puts

Call options by funds: $1.4M | Put options by funds: $2.02M

36% less capital invested

Capital invested by funds: $2.36B [Q3] → $1.51B (-$855M) [Q4]

100% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 0 (-2) [Q4]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $12 37% upside
• Avg. target: $16.25 85% upside
• High target: $26 196% upside

8 analyst ratings

• positive: 5 63%
• neutral: 3 38%
• negative: 0 0%

Citigroup Patrick Donnelly 23% 1-year accuracy 7 / 31 met price target	71% upside $15	Buy Maintained	4 Mar 2025
Morgan Stanley Tejas Savant 21% 1-year accuracy 4 / 19 met price target	196% upside $26	Overweight Maintained	14 Feb 2025
Barclays Luke Sergott 22% 1-year accuracy 11 / 51 met price target	71% upside $15	Overweight Maintained	14 Feb 2025
Canaccord Genuity Kyle Mikson 33% 1-year accuracy 9 / 27 met price target	105% upside $18	Buy Maintained	13 Feb 2025
JP Morgan Rachel Vatnsdal 44% 1-year accuracy 7 / 16 met price target	37% upside $12	Neutral Maintained	13 Feb 2025